<DOC>
	<DOCNO>NCT02783690</DOCNO>
	<brief_summary>This open label phase II randomize control trial determine safety 15 fraction v 25 fraction pencil beam scan proton radiotherapy mastectomy patient require regional nodal irradiation . Proton therapy recognize standard option delivery radiotherapy breast cancer .</brief_summary>
	<brief_title>A Trial 15 Fraction v 25 Fraction Pencil Beam Scanning Proton Radiotherapy After Mastectomy Patients Requiring Regional Nodal Irradiation</brief_title>
	<detailed_description />
	<criteria>Inclusion Criteria Age ≥ 18 year Histologic confirmation breast cancer resect mastectomy without immediate reconstruction chest wall regional nodal irradiation plan . pStage T1T4N0N3M0 ypStage T04N0N3M0 Note : The axilla must stag sentinel node biopsy alone , sentinel node biopsy follow axillary node dissection , axillary lymph node dissection alone ECOG Performance Status ( PS ) 0 2 . ( Appendix I ) . Negative pregnancy test do ≤7 day prior registration , woman childbearing potential . Radiotherapy must begin within 12 week last surgery ( breast axilla ) last chemotherapy . Note : Breast implant expanders allow Able provide IRB approve study specific write informed consent Ability complete questionnaire ( ) assistance Able complete mandatory test list section 4.0 Willing return enrol institution followup ( active monitoring phase study ) Willing provide tissue blood sample correlative research purpose . Rochester Arizona patient : Willing sign consent onto Mayo Clinic Radiotherapy Patient Outcomes Registry Biobanking study , IRB number 15000136 Rochester patient : Willing sign consent onto Evaluation cardiac function patient undergo proton beam photon radiotherapy , IRB number 15007443 Medical contraindication receipt radiotherapy . Severe active comorbid systemic illness severe concurrent disease , judgment investigator , would make patient inappropriate entry study interfere significantly proper assessment safety toxicity prescribe regimen . Uncontrolled intercurrent illness include , limited , ongoing active infection , symptomatic congestive heart failure , unstable angina pectoris , cardiac arrhythmia , psychiatric illness/social situation would limit compliance study requirement provide informed consent . Active systemic lupus scleroderma . Pregnancy woman childbearing potential sexually active willing/able use medically acceptable form contraception Prior receipt ipsilateral breast chest wall radiation would result significant overlap radiation therapy field . Prior contralateral radiotherapy breast cancer allow . Positive margin definitive surgery History nonbreast malignancy ( except situ cancer treat local excision basal cell squamous cell carcinoma skin ) within 5 year prior study entry Inflammatory breast cancer Recurrent Breast Cancer Boosts chest wall mastectomy . Nodal boost allow .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>